NXN-413 (Neuraxon)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameNXN-413 (Neuraxon)

Drug Alias NameNXN-413

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNitric-oxide synthase, brain inhibitors

TargetsNitric-oxide synthase, brain

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNeuraxon Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNeuraxon Inc

Active IndicationsN/A

Inactive IndicationsParkinson Disease

ATC CodeN/A